Mesenchymal stromal cell‐derived syndecan‐2 regulates the immune response during sepsis to foster bacterial clearance and resolution of inflammation

Sepsis is a life‐threatening process related to a dysregulated host response to an underlying infection, which results in organ dysfunction and poor outcomes. Therapeutic strategies using mesenchymal stromal cells (MSCs) are under investigation for sepsis, with efforts to improve cellular utility. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Junwen, Shi, Yuanyuan, Willis, Gareth, Imani, Jewel, Kwon, Min‐Young, Li, Gu, Ayaub, Ehab, Ghanta, Sailaja, Ng, Julie, Hwang, Narae, Tsoyi, Konstantin, El‐Chemaly, Souheil, Kourembanas, Stella, Mitsialis, S. Alex, Rosas, Ivan O., Liu, Xiaoli, Perrella, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766882/
https://www.ncbi.nlm.nih.gov/pubmed/34355516
http://dx.doi.org/10.1111/febs.16154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766882/
https://www.ncbi.nlm.nih.gov/pubmed/34355516
http://dx.doi.org/10.1111/febs.16154

Ejemplares similares